Bio-Rad Laboratories 

0
117
+$0.00+0% 00:00 今天

統計

當日最高
-
當日最低
-
52週高點
-
52週低點
-
成交量
-
平均成交量
-
市值
0
本益比
-
股息殖利率
-
股息
-

財報

30Apr預期
Q4 2024
Q1 2025
Q3 2025
Q4 2025
Q1 2026
1.85
2.2
2.55
2.9
預期EPS
1.871049
實際EPS
不適用

財務

-71.86%利潤率
未盈利
2019
2020
2021
2022
2023
2024
2.57B營收
-1.84B淨利

分析師評級

303.33平均目標價
最高預估為 320.00。
來自過去6個月內的 3 則評分。這不是投資建議。
買入
33%
持有
67%
賣出
0%

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
Show more...
執行長
Mr. Norman D. Schwartz
員工
7700
國家
美國

上市

0 Comments

分享你的想法

FAQ

Bio-Rad Laboratories 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 AMEX 交易所,Bio-Rad Laboratories 的股票以代號 BIO A 進行交易。
Bio-Rad Laboratories 去年的營收是多少?
Bio-Rad Laboratories 去年的營收為 2.57BUSD。
Bio-Rad Laboratories 去年的淨利是多少?
BIO A 去年的淨收益為 -1.84BUSD。
Bio-Rad Laboratories 有多少名員工?
截至 July 12, 2026,公司共有 7,700 名員工。
Bio-Rad Laboratories 位於哪個產業?
Bio-Rad Laboratories從事於Health & Wellness產業。
Bio-Rad Laboratories 何時完成拆股?
Bio-Rad Laboratories 最近沒有進行任何拆股。
Bio-Rad Laboratories 的總部在哪裡?
Bio-Rad Laboratories 的總部位於 美國 的 Hercules。